BioSpace News Archive

Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that it will release its financial results for the first quarter ended March 31, 2023, on Thursday, May 11, 2023, after the market close.

Twist Bioscience Corporation and Aster Insights today announced the availability of the AsterExome panel, which can simultaneously enable whole exome sequencing (WES) with additional coverage for target regions known to contain 620 genes associated with cancer.

BioMed X announced the expansion of its collaboration with Boehringer Ingelheim with the launch of a new model for biomedical research: XSeed Labs.

The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 54 cents per share of common stock.

Pattern Bioscience, Inc. today announced the completion of a $28.7 million Series C financing.

Cryoport, Inc. today announced that the Company will report financial results for the first quarter ended March 31, 2023.

Perimeter Medical Imaging AI, Inc. announced that it will host an educational symposium featuring the Perimeter S-Series OCT technology at the upcoming annual meeting of the American Society of Breast Surgeons taking place April 26-30, 2023 at the John B. Hynes Veterans Memorial Convention Center in Boston, MA.

RenovoRx, Inc announced today that Robert J. Spiegel, MD, has been appointed to the Company’s Board of Directors, effective April 25, 2023.

Butterfly Network, Inc. announced that it will report first quarter 2023 financial results and provide a business update on May 11, 2023, before the market opens.

Capricor Therapeutics announced the publication of a preclinical study in Microbiology Spectrum, a leading peer-reviewed scientific journal of the American Society for Microbiology, highlighting the therapeutic potential of its StealthX™ exosome platform technology to develop a multivalent vaccine against the spike and nucleocapsid SARS-CoV-2 proteins.